Anavex Life Sciences Corp (AVXL)

[nidan7500]

CNS JUST takes longer...according to this research paperIMO, BUT... when the S1R-AVXL MOA model is validated then the entire process will be accelerated dramatically. That will happen b/c when CNS root cause is narrowed to a smaller field of possibilities/ understood then refined/indication specifics will be more easily determined. When precise root cause models are available then it is only a simple matter of time until specifics can be precisely trialed and understood. Trials then will be able to focus on proof of efficacy, leading to exact CNS specific indication treatments.

When disease root cause is known then solutions will quickly follow. IMO, that is the path Dr.M. has chosen for AVXL. Sadly this process presents itself as standard hacking around in the dark using outdated required regulatory trial methods. I just hope we get there soon.


https://www.globenewswire.com/news-release/2018/09/11/1569156/0/en/CNS-Drugs-Take-20-Longer-to-Develop-and-38-Longer-to-Approve-vs-Non-CNS-Drugs-According-to-the-Tufts-Center-for-the-Study-of-Drug-Development.html